Pages

▼
Wednesday, June 17, 2015

Alzheimer's risk may be predicted by blood protein

›
Researchers have discovered a blood protein that could indicate the development of mild cognitive impairment - a condition associated with a...

Redrawing the brain's motor map

›
Black indicates neck area of motor cortex identified by Penfield + Rasmussen in 1950. Red indicates neck area identified by other studies,...

First presentation of data from NEUPRO (rotigotine transdermal patch) Phase 3 study in China announced

›
June 17, 2015 CB has announced efficacy and safety data from a Phase 3 study evaluating NEUPRO® (rotigotine transdermal patch) in the t...

Titan Pharmaceuticals : Presents Nonclinical Data Supporting Use of ProNeura Drug Delivery Platform in Parkinson's Disease

›
SOUTH SAN FRANCISCO, CA--(Marketwired - Jun 17, 2015) -   Titan Pharmaceuticals, Inc. ( OTCQB :  TTNP ) today presented nonclinical...

PROTHENA PRESENTS CLINICAL RESULTS DEMONSTRATING ROBUST, RAPID REDUCTION IN LEVELS OF FREE SERUM ALPHA-SYNUCLEIN OF UP TO 96% AFTER SINGLE DOSE OF PRX002, NOVEL PROTEIN IMMUNOTHERAPY FOR PARKINSON'S DISEASE

›
PRX002 was Safe and Well Tolerated; Phase 1 Single Ascending Dose Study Objectives Met Dose- and Time-Dependent, Statistically S...
Tuesday, June 16, 2015

Regular Exercise Found to Slow Decline in Parkinson’s Disease

›
  EMBARGOED until Wednesday, June 17, 2015 Media Contact: Elizabeth Clausen, +1 414-276-2145,  eclausen@movementdisorder...

Researchers develop new technique for modeling neuronal connectivity using stem cells

›
An example of TH-positive projections (red) from the inner chamber to the area of the outer chamber after 21 days. Scale bar = 100 ?m. GFP...

LCT' phase I/IIa study of NTCELL in Parkinson’s disease meets primary endpoint

›
Auckland, New Zealand Tuesday, June 16, 2015, 10:00 Hrs  [IST] Living Cell Technologies Limited (LCT) announced results from...

Acorda Presents Data on Inhaled Levodopa Therapy CVT-301 at International Congress of Parkinson's Disease and Movement Disorders

›
June 16,2015 Acorda Presents Data on Inhaled Levodopa Therapy CVT-301 at International Congress of Parkinson's Disease and Move...